|
|
|
|
Register for our Spring Meeting - Friday, March 27!
Book today for the best hotel rate, and join us in Montpelier, Vermont for our Spring Meeting.
Keynote speaker Congressman Peter Welch, and presentations on 340B; biogenerics legislation; importation; federal and state Sunshine Laws; trade policy & access to medicines; investigating CVS Caremark. More>>
|
NLARx News
NLARx Chair D.C. Councilmember David Catania, past Chair Massachusetts Senator Mark Montigny and Executive Director Sharon Treat presented at Washington, D.C. Summit on Disclosure, Transparency & Aggregate Spend. See presentations on conference website for Day 1 and Day 2.
A New Sheriff on the Block More
Pizza, Pads, Prescriptions And Subscriptions More
|
In the States
ALABAMA: State Seeks $170M in Lawsuit Alleging Generic Drugmaker Sandoz Overcharged Medicaid More
ARIZONA: Senator Burton Cahill Introduces Marketing and Gift Ban Legislation More
COLORADO: Senate Gives Preliminary Approval to Bill to Repeal Prescription Drug Program More
ILLINOIS: Representatives Jack D. Franks and Fred Crespo Introduce Disclosure Bill More
IOWA: Gift Ban and Academic Detailing Bill Amended and Passed by Health Committee More
Bill Limits Marketers' Use of Prescription Data, Requires Gift Disclosure, Regulates PBMs More
MASSACHUSETTS: Legislature to Hold Hearings on Four Datamining Bills More
MINNESOTA: Hearings on Several Pharmaceutical Bills Scheduled for March 2009 More
NEW YORK: Medicaid Fraud Recoveries Exceeding Expectations More
OREGON: NLARx Testimony in Support of HB 2376 Before the Oregon Healthcare Commitee More
WASHINGTON: Patient Privacy Act Withdrawn More |
Outrages of the Week
AstraZeneca Alledgedly Gave Sales Force False Information on Seroquel Risks More
States Say Medscape CME Part of Off-Label Promotion Scheme More
|
Fraud & Abuse
Justice Dept Files Suit Against Forest Labs for Illegally Marketing Celexa, Lexapro for Children More
Whistleblower Tags Amgen With Marketing Suit More
Unsealed Documents Raise Seroquel Questions More
Another Drug Company Accused of Hiding Negative Study Results More
|
Prices and Access to Healthcare
Many U.S. Residents Younger Than Age 65 Lacked Health Insurance During Past Two Years More
Shifting High Cost of Drugs to Consumers More
Study: 75% of U.S. Health Plans Reimburse for Off-Label Uses of Prescription Drugs More
Employers Plan To Reduce Contributions to Employees' Premiums in 2010, Survey Says More
Pfizer Worries Over Drug Studies as Obama Weighs Health Changes More
Electronic Records: Will They Cut Costs? More |
Reimportation
Sens. Dorgan, Snowe, McCain, Stabenow Introduce Bipartisan Prescription Drug Importation Bill More
Sens. Dorgan, McCain, Snowe Introduce Bill To Allow Prescription Drug Reimportation More
Reps. Berry and Emerson Introduce Bill to Lower Prescription Drug Costs More
PhRMA Statement on Prescription Drug Importation Legislation More
Obama's Cross-Border Prescription Drug Trade Plans Watched Closely More
|
Goings on in Washington, DC
Bill Requiring Companies to Report Payments To Doctors Will Pass in 2009, Expert Predicts More
Kansas Gov. Sebelius Tapped to Head HHS More
Interview with Senate Finance Committee Chairman Max Baucus More
Report: Health IT Funding in Stimulus Package Might Not Spur Technology Adoption More
|
Pharma Watch
Sen. Hatch's Hidden Financial Ties to Pharmaceutical Firms More
Health Care Sector Has Donated Millions of Dollars to Key Lawmakers More
Valeant Slashes Research as Solution to Drug Pipeline Woes More
Sanofi-Aventis CEO Looks to Cut Research Spending More
Drugmakers Have Begun Consolidation Drive That Is Redrawing the Industry Landscape More
Merck to Buy Schering-Plough for $41 Billion More
Merck, Schering to Cut 16,000 Post-Merger More
Genentech Near Deal to Sell Biotech Company for $95 a Share to Roche More
Pfizer Buys Rights to Sell More Generics More
As Innovation Shifts to Small Companies, How Will Big Pharma Defend High Drug Costs? More
Drug Middlemen May Feel Pharma Consolidation Pressure More
Merck Execs Pull Down $36M in Pay More
|
Advertising and Marketing
FDA Calls Glaxo Ad for Prostate Drug 'Misleading' More
BIO Urges Members to Adopt Code
Governing Interactions With Doctors More
Researchers To Ask FDA Panel To Require Rx Drug 'Fact Boxes' on Some Advertisements More
|
Conflicts of Interest
Federal Health Officials, Prosecutors Switch Focus to Physicians in Illegal Kickback Cases More
Lobbying of FDA Led to Fast-Track Review of Medical Device More
Grassley Asks Pfizer About Harvard Payments More
Harvard Med School in Ethics Quandary More
Harvard Med School Committee To Meet To Address Conflict of Interest Policies More
University of Minnesota to Put Industry Payments to Med School Faculty Online More
New Rules on Conflicts Proposed at University of Wisconsin More
|
PBM Watch
Maryland's CVS Caremark Contract Audit Reveals Questionable Payments More
Transparency Fight over CVS Caremark Contracting Practices More
CVS Caremark Shuts Doors of 16% of Its Walk-In MinuteClinic Locations More
Report: WellPoint to Sell Pharmacy Benefits Management Business More
Bill Would Allow Community Pharmacies to Negotiate with PBMs More
|
Medicare
Most Seniors Did Not Make the Best Possible
Financial Decision In Choosing Part D Drug Plan More
|
Medicaid
Baxter Settles Medicaid Case for $1 Million More
|
Patents and Generics
GPhA Statement on AARP Study on Biogeneric Approval Path for High Cost Specialty Drugs More
Generic Biologics Face Long, Tough Road More
AstraZeneca Goes Into Battle to Defend Crestor More
|
Safety and Clinical Trials
Supreme Court Rejects Limits on Drug Lawsuits More
Supreme Court Protects Consumer Rights More
Different Rules for Suing Device, Drug Makers More
Acting FDA Commissioner Lays Out Quality Plan More
Comparative Effectiveness Panel Missing Consumer Representatives More
NEJM: Increasing Globalization of Clinical Trials Raises Scientific, Ethical Issues More
Pharmacies Offering No-Cost Antibiotics Should Promote Responsible Use, CDC Says More
Ranbaxy Compliance Issues Mount, FDA Halts Application Reviews More
New Use for Erbitux Stalled by FDA's Data Request More
AstraZeneca Warned Japanese Doctors of Diabetes Link More
Study: Other Drugs May Limit Plavix's Effectiveness More |
Editorials and Op-Eds
FDA Must Modernize Its Approval System for Extended Release Drugs More
|
|
|
|
|
|
|
